< Back
EMWA Logo EMWA Logo
 

Tiziana von Bruchhausen

Company:
Boehringer Ingelheim
Qualification:
PhD
Leader background:
After spending almost 10 years in basic research, in 2008 Tiziana moved to the pharmaceutical field and specialised in pharmacovigilance and medical writing. She worked in a contract research organisation and as a freelance writer for mid-sized and large pharmaceutical companies. In her current position of Senior Global Pharmacovigilance Writer at Boehringer Ingelheim, she is responsible for pharmacovigilance document preparation and coordination, strategic planning, and responses to regulatory authorities. Since 2012, Tiziana has being promoting pharmacovigilance within the medical writing community by holding workshops for various international institutions, chairing sessions at conferences, and through the European Medical Writers Association (EMWA). In 2017, Tiziana was elected Chair of the EMWA’s Pharmacovigilance Special Interest Group and Vice President/President (2017-2019).
Workshops:
Risk Management Plans: Challenges and insights
    Level: Advanced Area: Drug Development
    Code: DDA20 Duration: 03:30:00
Writing Risk Management Plans
    Level: Foundation Area: Drug Development
    Code: DDF30 Duration: 03:30:00
Introduction to Pharmacovigilance Writing
    Level: Foundation Area: Drug Development
    Code: DDF32 Duration: 03:00:00
Post-submission Pharmacovigilance Writing: Interactions with Authorities and Impact on RMPs and PSURs
    Level: Advanced Area: Drug Development
    Code: DDA26 Duration: 03:30:00
Periodic Benefit-Risk Evaluation Reports
    Level: Advanced Area: Drug Development
    Code: DDA14b Duration: 03:30:00
Introduction to Pharmacovigilance Writing
    Level: Foundation Area: Drug Development
    Code: DDF32a Duration: 03:00:00
Writing Development Safety Update Reports
    Level: Advanced Area: Drug Development
    Code: DDA32 Duration: 03:30:00
Writing Development Safety Update Reports
    Level: Advanced Area: Drug Development
    Code: DDA32a Duration: 03:30:00
Introduction to Pharmacovigilance Writing
    Level: Foundation Area: Drug Development
    Code: DDF32b Duration: 03:00:00